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Introduction
Polyarteritis nodosa (PAN) is a systemic necrotizing vas-
culitis of middle-sized arteries, found in both adults and
children. Disease pathogenesis is poorly understood. We
identified multiple cases of systemic PAN and cutaneous
PAN in families and individuals of Georgian-Jewish
ancestry, consistent with autosomal recessive inheritance.
While most cases (17/20) had childhood onset, cutaneous
PAN could also initiate in middle age.
Objectives
To determine the genetic basis of monogenic PAN.
Methods
Exome sequencing of 4 affected individuals from 2 families
was followed by targeted sequencing of 16 additional
Georgian-Jewish cases and 6 Turkish pediatric cases
of PAN. Mutations were assayed by protein structure
analysis, expression in mammalian cells, biophysical
analysis of purified protein, and enzymatic activity in
patient sera.
Results
Missense mutation CECR1 p.G47R (c.139G>A), in the
gene encoding ADA2, was the only damaging variant
homozygous in all 4 exomes. Of the 20 Georgian-Jewish
patients, 19 were homozygous for this mutation and one
was compound heterozygous for G47R and H391Y. One
Turkish patient was compound heterozygous for G47V
and W264S. In the Georgian-Jewish population, the
frequency of G47R was 0.05, reflecting the high prevalence
of PAN in this endogamous community. The other muta-
tions were absent from ethnically matched controls.
ADA2 activity was significantly reduced in patient sera.
Expression of mutant proteins in HEK293T cells yielded
significantly reduced levels of secreted ADA2 and biophy-
sical assays indicated reduced protein stability.
Conclusion
We report mutations in the gene encoding ADA2 as the
first genetic cause of a systemic vasculitis. ADA2 is the
major extra-cellular ADA, so blood vessels may be parti-
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